ASX:LCT Living Cell Technologies (LCT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Living Cell Technologies Stock (ASX:LCT) 30 days 90 days 365 days Advanced Chart Get LCT alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,622 shsAverage VolumeN/AMarket CapitalizationA$24.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia. Read More Receive LCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LCT Stock News HeadlinesScientists create first-ever “living computer” made of cellsSeptember 9, 2025 | msn.comScientists create first-ever “living computer” made of cellsSeptember 9, 2025 | msn.comReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves. | Banyan Hill Publishing (Ad)‘Living computers’: Scientists plan to turn bacteria into digital processorsSeptember 3, 2025 | msn.comUncovering how cells allocate space to make way for new growthJune 8, 2025 | msn.comCellVoyant's AI-Powered Vision for the Future of Cell TherapyApril 16, 2025 | msn.comSuper-resolution imaging technology reveals inner workings of living cellsApril 2, 2025 | msn.comMysterious stem cells: LCT procedure (3)December 29, 2024 | msn.comSee More Headlines LCT Stock Analysis - Frequently Asked Questions How were Living Cell Technologies' earnings last quarter? Living Cell Technologies Limited (ASX:LCT) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $0.00 earnings per share (EPS) for the quarter. What other stocks do shareholders of Living Cell Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), Cheniere Energy (LNG) and AllianceBernstein Global High Income Fund (AWF). Company Calendar Last Earnings2/19/2019Today9/15/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:LCT CIKN/A Webwww.lctglobal.com Phone61 3 8689 9997FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$2.11 million Net MarginsN/A Pretax MarginN/A Return on Equity-54.06% Return on Assets-18.67% Debt Debt-to-Equity RatioN/A Current Ratio9.35 Quick Ratio17.84 Sales & Book Value Annual SalesA$3.41 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.17 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket CapA$24.53 million OptionableNot Optionable Beta0.48 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:LCT) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Living Cell Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Living Cell Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LCT Stock Alerts